Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Thomas Stephan upgrades Staar Surgical (STAA) from Hold to Buy and increases the price target from $30 to $50.
March 11, 2024 | 8:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical's stock rating was upgraded by Stifel analyst Thomas Stephan from Hold to Buy, with a significant increase in the price target from $30 to $50.
An upgrade from Hold to Buy typically signals a positive outlook on the stock by analysts, suggesting an expectation of outperformance in the near term. The substantial increase in the price target from $30 to $50 further underscores a strong confidence in the company's future performance, likely leading to increased investor interest and potentially a rise in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100